Gene · 170482
Papers2,250
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
301 to 320 of 2,250
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| An epithelial-immune circuit amplifies inflammasome and IL-6 responses to SARS-CoV-2. | Cell Host Microbe | 2023 | 36563691 | PubTator, text mining | PubMed |
Impact of BNT162b2 mRNA anti-SARS-CoV-2 vaccine on interferon-alpha production by plasmacytoid dendritic cells and autoreactive T cells in patients with systemic lupus erythematosus: The COVALUS project. | J Autoimmun | 2023 | 36563528 | PubTator, text mining | PubMed |
| Multiparameter flow cytometry in the evaluation of myelodysplasia: Analytical issues: Recommendations from the European LeukemiaNet/International Myelodysplastic Syndrome Flow Cytometry Working Group. | Cytometry B Clin Cytom | 2023 | 36537621 | PubTator, text mining | PubMed |
| Circulating CD22+/CD19-/CD24- progenitors and CD22+/CD19+/CD24- mature B cells: Diagnostic pitfalls for minimal residual disease detection in B-lymphoblastic leukemia. | Cytometry B Clin Cytom | 2023 | 36433814 | PubTator, text mining | PubMed |
| Prognostic effects of the gastric mucosal microbiota in gastric cancer. | Cancer Sci | 2023 | 36403134 | PubTator, text mining | PubMed |
| Myeloid-derived suppressor cells and plasmacytoid dendritic cells are associated with oncogenesis of oral squamous cell carcinoma. | J Oral Pathol Med | 2023 | 36380437 | PubTator, text mining | PubMed |
| Single-cell RNA sequencing analysis revealed cellular and molecular immune profiles in lung squamous cell carcinoma. | Transl Oncol | 2023 | 36270103 | PubTator, text mining | PubMed |
| Cutaneous Involvement in Systemic Lupus Erythematosus: A Review for the Rheumatologist. | J Rheumatol | 2023 | 36109075 | PubTator, text mining | PubMed |
| A unique immune signature in blood separates therapy-refractory from therapy-responsive acute graft-versus-host disease. | Blood | 2023 | 36044666 | PubTator, text mining | PubMed |
Distinct blood protein profiles associated with the risk of short-term and mid/long-term clinical relapse in patients with Crohn's disease stopping infliximab: when the remission state hides different types of residual disease activity. | Gut | 2023 | 36008101 | PubTator, text mining | PubMed |
| Expansion of Phenotypically Altered Dendritic Cell Populations in the Small Airways and Alveolar Parenchyma in Patients with Chronic Obstructive Pulmonary Disease. | J Innate Immun | 2023 | 35998572 | PubTator, text mining | PubMed |
| The liver cancer immune microenvironment: Therapeutic implications for hepatocellular carcinoma. | Hepatology | 2023 | 35989535 | PubTator, text mining | PubMed |
| Single-cell transcriptomic landscape identifies the expansion of peripheral blood monocytes as an indicator of HIV-1-TB co-infection. | Cell Insight | 2022 | 37192986 | PubTator, text mining | PubMed |
| Drugs to limit Zika virus infection and implication for maternal-fetal health. | Front Virol | 2022 | 37064602 | PubTator, text mining | PubMed |
| Impaired Antitumor Immune Response in MYCN-amplified Neuroblastoma Is Associated with Lack of CCL2 Secretion and Poor Dendritic Cell Recruitment. | Cancer Res Commun | 2022 | 36923280 | PubTator, text mining | PubMed |
| A multi-use deep learning method for CITE-seq and single-cell RNA-seq data integration with cell surface protein prediction and imputation. | Nat Mach Intell | 2022 | 36873621 | PubTator, text mining | PubMed |
| The role of innate immune cells in the tumor microenvironment and research progress in anti-tumor therapy. | Front Immunol | 2022 | 36741415 | PubTator, text mining | PubMed |
| Multimodal human thymic profiling reveals trajectories and cellular milieu for T agonist selection. | Front Immunol | 2022 | 36741401 | PubTator, text mining | PubMed |
| Targeting type I interferons in systemic lupus erythematous. | Front Pharmacol | 2022 | 36726783 | PubTator, text mining | PubMed |
| Effect of early postnatal supplementation of newborns with probiotic strain E. coli O83:K24:H31 on allergy incidence, dendritic cells, and microbiota. | Front Immunol | 2022 | 36703968 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/170482/papers?page=16